简介：AbstractBackground:With current chemotherapy treatment, >90% of survival has been obtained for Burkitt lymphoma (BL). In this study, the demographic characteristics and treatment outcomes are presented for 78 children in China with central nervous system-positive (CNS+) BL.Methods:This retrospective study consecutively enrolled 78 CNS+ BL patients in Beijing Children’s Hospital (BCH) from 2007 to 2019 who received the BCH B-cell non-Hodgkin’s lymphoma regimen (modified by French-American-British mature lymphoma B-cell 96 [FAB/LMB96] C1 arm ± rituximab). Clinical characteristics, methods of disease detection in the CNS, and outcomes were evaluated. Univariate and multivariate analyses were used to assess prognostic factors.Results:The median age of 65 boys and 13 girls at the time of diagnosis was 5.7 years (ranging from 1 to 14 years). Patients were followed up for a median time of 34 months (ranging from 1 to 72 months). Bone marrow invasion was found in 38 (48.7%) patients. There were 48 (61.5%), 44 (56.4%), and 25 (32%) patients with cranial nerve palsy, intracerebral mass (ICM), and parameningeal extension, respectively. Abnormal cerebrospinal fluid (CSF) morphology and CSF immunophenotype appeared in 15 (19.2%) and 15 (19.2%) patients, respectively. There were 69 (88.5%) patients treated with chemotherapy combined with rituximab, and nine patients were treated solely with chemotherapy. Finally, five patients died of treatment-related infection, recurrence occurred for 13, and one developed a second tumor. The 3-year overall survival and event-free survival rates were 78.9% ± 4.7% and 71.4% ± 6.0%, respectively. Treatment with chemotherapy only, ICM positivity, and >4 organs involved at diagnosis were independent risk factors.Conclusions:Rituximab combined with a modified LMB96 regimen has greatly increased the efficacy of treatment for Chinese children with CNS+ BL, and with the continuous collection of outcome data, treatment-related complications are decreasing. For further verification, a large sample multicentre randomized controlled study should be performed to explore a treatment scheme for Chinese children with even greater efficacy.

简介：

简介：AIMTo比较fluorometholone的联合0.1%并且0.5%在控制发炎并且与intraocular透镜implantation.METHODSSixty在phacoemulsification以后阻止感染掉到tobramycin/dexamethasone眼睛的levofloxacin从60看经历奔流phacoemulsification的病人被使随机化进二个组；病人的一半与与levofloxacin(4times/d)相结合的fluorometholone(6times/d)被对待，当另外的一半与眼睛掉一个星期的tobramycin/dexamethasone(4times/d)被对待时。在操作和1wk追随者treatments.RESULTSThere不是在角膜的厚度(P0.629)的二个组之间的统计上重要的差别以前，外科手术前、手术后的intraocular压力，水的闪光，角膜的厚度，和症状被记录，水的闪光(P0.398)，并且症状分数(P0.350)在每次指。眼睛的高血压仅仅在与levofloxacin治疗表演相结合的tobramycin/dexamethasonegroup.CONCLUSIONFluorometholone在二只眼睛被观察可比较的功效但是没有增加intraocular压力的趋势；因此，它可能是为手术后的使用的更好的政体。

简介：Objective:B-celllymphoma2(Bcl-2)isanimportantmemberoftheBcl-2familyofproteinsthatregulatetheinductionofapoptosis.ThisstudyaimstoinvestigatewhetherBcl-2smallinterferingRNA(siRNA)combinedwithmiR-15aoligonucleotides(ODN)couldenhancemethotrexate(MTX)-inducedapoptosisinRajicells.Methods:ChemicallysynthesizedmiR-15aODNandBcl-2siRNAweretransfectedinRajicellsbyusingaHiPerFectTransfectionReagentandthencombinedwithMTX.ExpressionlevelsofBcl-2proteinweredetectedbyWesternblot.CellproliferationwasdeterminedbyCCK8assay.TherateofcellapoptosiswasdeterminedbyAnnexinV/PIdoublestaining.ThemorphologyofapoptoticcellswasobservedbyHoechst-33258staining.Results:AfterthecellsweretransfectedwithmiR-15aODNcombinedwithBcl-2siRNA,Bcl-2proteinlevelswereevidentlydecreased.CCK8assayshowedthatcellproliferationwassignificantlydecreasedandwassignificantlylowerinmiR-15aODNcombinedwithBcl-2siRNAplusMTXgroupthaninmiR-15aODNwithmethotrexategroup,Bcl-2siRNAwithMTXgroup,andsingleMTXgroup(P<0.05).Hoechst33258stainingrevealednumerousapoptoticcells.AnnexinV/PIdoublestainingshowedthattheapoptoticrateswere(13.13±1.60)%,(34.47±2.96)%,(32.87±3.48)%,and(45.47±2.16)%inMTX,Bcl-2siRNAplusMTX,miR-15aODNplusMTX,andmiR-15aODNcombinedwithBcl-2siRNAplusMTXgroups,respectively.Amongthesegroups,theapoptoticrateofmiR-15aODNcombinedwithBcl-2siRNAplusMTXgroupwasthehighest;thisapoptoticratewasalsosignificantlydifferentfromthatofmiR-15aODNorBcl-2siRNAplusMTX(P<0.05).Conclusions:Bcl-2siRNAcombinedwithmiR-15aODNcouldenhanceMTX-inducedapoptosisinRajicells.Bcl-2siRNAandmiR-15acombinedwithMTXmaybeausefulapproachtoimprovethetreatmenteffectsonlymphoma.更多还原

简介：Removalofsinglecomponentandbinarymixturesofbenzeneandm-xyleneusingamulti-pin-meshreactorwasstudiedtofindthedecompositioncharacteristics,carbonbalanceandCO_2selectivity.Thedecompositionrateofbenzeneinmixturewasapproximately16%lowerthanthatofsinglecomponentbenzene.However,thedecompositionrateofm-xyleneinmixturewasslightlyhigherthanthatofsinglecomponentm-xylene.Carbonbalanceofthemixturedecompositionprocessachievedalowerlevelthanthatofsinglecomponentbenzene/m-xylene.IncreaseinthespecificinputenergywashelpfultoimproveCO_2selectivityinthesinglecomponentdecompositionprocess,whilethespecificinputenergyhadanegligibleeffectonCO_2selectivityinthemixturedecompositionprocess.Bychangingtheoxygencontentinbackgroundgas,wefoundthatdifferenttypesofradicalsshoweddifferentreactionactivitiestowardbenzeneandm-xylene.Benzenewasmorelikelytoreactwithnitrogen-containingradicals,whilem-xylenewasmorelikelytoreactwithoxygen-containingradicals.

简介：

简介：AbstractBackground:The calcineurin inhibitor (CNI)-based immune maintenance regimen that is commonly used after renal transplantation has greatly improved early graft survival after transplantation; however, the long-term prognosis of grafts has not been significantly improved. The nephrotoxicity of CNI drugs is one of the main risk factors for the poor long-term prognosis of grafts. Sirolimus (SRL) has been employed as an immunosuppressant in clinical practice for over 20 years and has been found to have no nephrotoxic effects on grafts. Presently, the regimen and timing of SRL application after renal transplantation vary, and clinical data are scarce. Multicenter prospective randomized controlled studies are particularly rare. This study aims to investigate the effects of early conversion to a low-dose CNI combined with SRL on the long-term prognosis of renal transplantation.Methods:Patients who receive four weeks of a standard regimen with CNI + mycophenolic acid (MPA) + glucocorticoid after renal transplantation in multiple transplant centers across China will be included in this study. At week 5, after the operation, patients in the experimental group will receive an additional administration of SRL, a reduction in the CNI drug doses, withdrawal of MPA medication, and maintenance of glucocorticoids. In addition, patients in the control group will receive the maintained standard of care. The patients’ vital signs, routine blood tests, routine urine tests, blood biochemistry, serum creatinine, BK virus (BKV)/cytomegalovirus (CMV), and trough concentrations of CNI drugs and SRL at the baseline and weeks 12, 24, 36, 48, 72, and 104 after conversion will be recorded. Patient survival, graft survival, and estimated glomerular filtration rate will be calculated, and concomitant medications and adverse events will also be recorded.Conclusion:The study data will be utilized to evaluate the efficacy and safety of early conversion to low-dose CNIs combined with SRL in renal transplant patients.Trial registration:Chinese Clinical Trial Registry, ChiCTR1800017277.

简介：无

简介：AbstractBackground:Contrast-enhanced ultrasound (CEUS) can detect lesions hidden in inflammatory regions and find necrosis or areas of severe fibrosis within the lesion. This retrospective study aimed to compare the diagnostic accuracy of solid pancreatic lesions using percutaneous ultrasound (US)-guided fine-needle aspiration (FNA) with or without CEUS assessment.Methods:Clinical, imaging, and pathologic data of 181 patients from January 2014 to December 2018 in Pecking Union Medical College Hospital, with solid pancreatic masses who underwent percutaneous US-FNA and ThinPrep cytologic test were retrospectively evaluated. Patients were divided into CEUS and US groups according to whether CEUS was performed before the biopsy. According to FNA cytology diagnoses, we combined non-diagnostic, neoplastic, and negative cases into a negative category. The positive category included malignant, suspicious, and atypical cases. The final diagnosis was confirmed by pathology or clinical and radiological follow-up for at least 12 months. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of US-FNA were evaluated between the two groups.Results:This study enrolled 107 male and 74 female patients (average age: 60 years). There were 58 cases in the US group and 123 cases in the CEUS group. No statistically significant differences in age, gender, or lesion size were found between the two groups. The diagnostic accuracy of the CEUS group was 95.1% (117/123), which was higher than the 86.2% (50/58) observed in the US group (P = 0.036). The sensitivity, specificity, PPV, and NPV of the CEUS group were increased by 7.5%, 16.7%, 3.4%, and 18.8%, respectively, compared with the US group. However, the differences of the two groups were not statistically significant.Conclusions:Compared with the conventional US, the use of CEUS could improve the biopsy accuracy and avoid the need for a repeat biopsy, especially for some complicated FNA cases.

简介：摘要ObjectiveThis research was designed to probe into the effects of fluoxetine combined with repetitive transcranial magnetic stimulation (rTMS) on the psychological emotions and the cognitive and neurological functions of acute post-stroke depression patients.MethodsThis experiment recruited 115 acute post-stroke depression patients who were treated in our hospital from February 2018 to April 2020 as the study cohort. 55 of the patients were treated with fluoxetine, and 60 were treated with fluoxetine combined with rTMS. Both groups were treated for 2 months. The self-rating anxiety scale (SAS), the self-rating depression scale (SDS), the National Institutes of Health stroke scale (NIHSS), the mini mental state scale (MMSE), the Barthel index, and the quality of life scale (SF-36) scores were observed.ResultsCompared with the control group (CG), the SAS, SDS, and NIHSS scores in the research group (RG) decreased, while the MMSE and Barthel index scores increased (P<0.05). After the treatment, the SF-36 scores in the RG were higher than they were in the CG (P<0.05)．ConclusionsFluoxetine combined with rTMS can effectively improve the psychological emotions and the cognitive and neurological functions of acute post-stroke depression patients, so it is worthy of clinical promotion.

简介：在这份报纸，我们独自考察了雄激素剥夺治疗(ADT)的长期的幸存结果，安全，和quality-of-life对为局部地先进、变形的前列腺癌症(PCa)与放射治疗(RT)或化疗结合了。文学搜索用OvidSP被执行。满足了下列标准的使随机化的控制试用(RCT)被包括：包括局部地先进或变形的PCa，比较方法和疾病的报导量的数据控制的与任何治疗独自一个对联合的ADT或幸存结果。最后，八RCT满足了包括标准。在这些之中，三比较了ADT对ADT正RT(n=2344)并且一个人比较了ADT对ADT正docetaxel-estramustine(n=413)在局部地先进的PCa；二比较了ADT对ADT正docetaxel(n=1175)并且加estramustine的二比较ADT对ADT(n=114)在变形PCa。为局部地先进的PCa，到长期的ADT的RT的增加能与充分可接受的不利效果改进幸存和肿瘤控制的结果。特殊，分享的机会比率(或)外套，幸存(OS)是1.43(95%信心间隔1.20-1.71)什么时候独自加RT把ADT与ADT作比较(P<0.0001)。为变形神经质地敏感的PCa，加ADT的docetaxel的并发的使用有效、安全(分享或OS：1.29[1.01-1.65]：P=0.04)。总共，加docetaxel的长期的ADT正RT和长期的ADT应该分别地在局部地先进、变形的神经质地敏感的PCa被看作合适的处理选择。为纸的主要限制是仅仅八RCT是可得到的。

简介：HyoscyamiSemen,thematuredriedseedofHyoscyamusnigerL.,haslongbeenusedasatraditionalChinesemedicinetotreathumandiseases.HyoscyamiSemenisfoundinlocalmarketsinChina.Inmarkets,sellersandbuyerscommonlyinadvertentlymixtheseedsofH.nigerwiththeseedsofrelatedspeciessuchasHygrophilasalicifolia(Vahl)Nees,AstragaluscomplanatusR.Br.,CuscutaaustralisR.Br.,CuscutachinensisLam.,andImpatiensbalsaminaL.becauseoftheirsimilarmorphologiesorsimilarnames.Thus,developingareliablemethodfordiscriminatingH.nigerseedsfromitsadulterantsisnecessarytoreduceconfusionandensurethesafeuseofHyoscyamiSemen.Thepresentstudywasdesignedtoevaluatetheefficiencyofhigh-resolutionmeltinganalysiscombinedwithDNAbarcoding(Bar-HRM)withinternaltranscribedspacer2todiscriminateH.niger.OurresultsshowthatBar-HRMsuccessfullyidentifiedtheadulterantsanddetectedtheproportionofH.nigerDNAextractwithinanadmixture.Inparticular,HRMdetectedH.nigerDNAextractinA.complanatusDNAextractatconcentrationsaslowas1%.Inconclusion,theBar-HRMmethoddevelopedinthepresentstudyforauthenticatingH.nigerisrapidandcost-effective.ItcanbeusedinthefuturetoguaranteethepurityofHyoscyamiSemenfortheclinicaluse.

简介：无

简介：AJNR,2008Jun26.BACKGROUNDANDPURPOSE:InclusionofoligodendroglialtumorsmayconfoundtheutilityofMRbasedgliomagrad-ing.Ouraimwas,first,toassessretrospectivelywhetherahistogram-analysismethodofMRperfusionimagesmaybothgrade

简介：Mentalretardation(MR)childrenarereferredtothosewhohavealowerintelligenceincomparisonwiththatofthenormalchildrenwithsimilaragesinthedevelopmenalstageandsomeconcurrentdefectsinadaptivebehaviorsimultaneously.Inthepastmorethan10years,we

简介：无

简介：为了观察中国草药的忿恨的效果，在endothelin(et)和calcitonin的集中上与三步的tuina操作结合了基因相关的肽(CGRP)和在有脊椎的动脉的病人的眩晕颈的spondylosis(休假)。

简介：AbstractBackground:Compared to adult studies, studies which involve the treatment of pediatric congenital hypogonadotropic hypogonadism (CHH) are limited and no universal treatment regimen is available. The aim of this study was to evaluate the feasibility of human chorionic gonadotropin (hCG)/human menopausal gonadotropin (hMG) therapy for treating male adolescents with CHH.Methods:Male adolescent CHH patients were treated with hCG/hMG (n = 20) or a gonadotropin-releasing hormone (GnRH) pump (n = 21). The treatment was divided into a study phase (0-3 months) and a follow-up phase (3-12 months). The testicular volume (TV), penile length (PL), penis diameter (PD), and sex hormone levels were compared between the two groups. The TV and other indicators between the groups were analyzed using a t-test (equal variance) or a rank sum test (unequal variance).Results:Before treatment, there was no statistical difference between the two groups in terms of the biochemistry, hormones, and other demographic indicators. After 3 months of treatment, the TV of the hCG/hMG and GnRH groups increased to 5.1 ± 2.3 mL and 4.1 ± 1.8 mL, respectively; however, the difference was not statistically significant (P > 0.05, t= 1.394). The PL reached 6.9 ± 1.8 cm and 5.1 ± 1 .6 cm (P < 0.05, t= 3.083), the PD reached 2.4 ± 0.5 cm and 2.0 ± 0.6 cm (P < 0.05, t= 2.224), respectively, in the two groups. At the end of 6 months of treatment, biomarkers were in normal range in the two groups. Compared with the GnRH group, the testosterone (T) level and growth of PL and PD were significantly greater in the hCG/hMG group (all P < 0.05). While the TV of both groups increased, the difference was not statistically significant (P > 0.05, t = 0.314). After 9 to 12 months of treatment, the T level was higher in the hCG/hMG group. Other parameters did not exhibit a statistical difference.Conclusions:The hCG/hMG regimen is feasible and effective for treating male adolescents with CHH. The initial 3 months of treatment may be a window to optimally observe the strongest effects of therapy. Furthermore, results from the extended time-period showed positive outcomes at the 1-year mark; however, the long-term effectiveness, strengths, and weaknesses of the hCG/hMG regimen require further research.Trial Registration:ClinicalTrials.gov, NCT02880280; https://clinicaltrials.gov/ct2/show/NCT02880280.

简介：AbstractBackground:Patients carrying the HongKongαα (HKαα) allele and -α3.7/αααanti-4.2 could be misdiagnosed as -α3.7/αα by the current conventional thalassemia detection methods, leading to inaccurate genetic counseling and an incorrect prenatal diagnosis. This study was aimed to accurately analyze the genotypes of HKαα carriers and -α3.7/αααanti-4.2.Methods:Samples were collected in our hospital from July 2017 to October 2019. Twenty-four common types of Chinese thalassemia were screened by gap-polymerase chain reaction (Gap-PCR) and reverse dot blot (RDB). Anti-4.2 multiplex-PCR was used to confirm carriers of the αααanti-4.2 duplication with -α3.7 deletion. Two-round nested PCR and multiplex ligation-dependent probe amplification (MLPA) were applied to accurately identify and confirm their genotypes. For data analysis, we used descriptive statistics and Fisher’s exact tests.Results:Two thousand five hundred and forty-four cases were identified as thalassemia in 5488 peripheral blood samples. The results showed that α, β, and αβ compound thalassemia were identified in 1190 (46.78%), 1286 (50.55%), and 68 (2.67%) cases, respectively. A total of 227 samples from thalassemia patients were identified as -α3.7/αα by Gap-PCR, and the genotypes of two samples were uncertain. There was a difference between Gap-PCR and combined groups (Gap-PCR combined with nested PCR and MLPA) in detecting HKαα (P < 0.05). Among the 229 patients, 20 patients were identified as HKαα carriers and one was identified as -α3.7/αααanti-4.2 by two-round nested PCR and MLPA, including 15 patients with HKαα/αα, three with HKαα/αα and β-thalassemia coinheritance, one with HKαα/-SEA, one with HKαα/-α4.2 and β-thalassemia coinheritance, and one with -α3.7/αααanti-4.2 and β-thalassemia coinheritance.Conclusions:αααanti-4.2 and HKαα genotypes of patients carrying -α3.7 need to be detected to reduce the misdiagnosis rate of patients carrying HKαα and -α3.7/αααanti-4.2 alleles. More accurate genetic counseling can be provided in the clinic using nested PCR combined with MLPA.

简介：以便解决DOA(到达的方向)的问题评价在水下远宽带目标，一个新奇协调signal-subspace方法基于十字光谱压力的矩阵和用声学的向量传感器数组(AVSA)的粒子速度在这份报纸被建议。建议方法与在把声学的向量传感器(AVS)的粒子速度信息用作一个独立人士的基于的DOA评价方法穿的存在AVSA不同元素。也就是，它完全基于压力和粒子速度的联合信息处理P-V生气光谱，在各向同性的噪音比存在方法有更好的DOA评价性能地。由理论分析，基于P-V集中原则和eigendecomposition理论的两个交叉光谱矩阵是given.At一样的时间，为数字察觉也是的来源的相应标准有从湖试用的数据的presented.Computer模拟证明建议方法是有效的并且显然超过存在在分辨率的方法和在低Signal-to-Noise比率(SNR)的情况中的精确性。